News Announcements

Vanderbilt’s Department of Radiology and Radiological Sciences will provide annual lead shielding inspections of lead-lined aprons, vests, skirts/kilts, thyroid collars, gonadal shields, gloves and vinyl-type mobile shields every Thursday from Oct. 2 to Dec. 11, from 3:30 to 9 p.m. The Tennessee Department of Health and Environment, Radiological Health Division, requires personal protective lead shielding be inspected. The Joint Commission on Accreditation of Healthcare Organizations and Vanderbilt require they be inspected visually and fluoroscopically each year.

"After an extensive national search, I am pleased to announce that Richard Pierce, MBA, CMPE will be joining the Department of Radiology and Radiological Sciences as our new Chief of Finance and Administration (CFA)," said Dr. Reed Omary, Chair of the department. "This position will help align the hospital and medical school sides of Vanderbilt Radiology. Rich will transition into this role with the help of Jim Patton, PhD, our current Vice Chair of Finance."

Researchers in the Vanderbilt University Institute of Imaging Science (VUIIS) have achieved the first conclusive non-invasive measurement of neural signaling in the spinal cords of healthy human volunteers. Their technique, described today in the journal eLife, may aid efforts to help patients recover from spinal cord injuries and other disorders affecting spinal cord function, including multiple sclerosis.

A Vanderbilt University Medical Center initiative being led by teams of resident physicians is reducing repetitive lab tests and making a visible impact on health care delivery.  

Interventional oncology has been called the fourth pillar of oncology—teaming up with medical oncology, surgical oncology, and radiation oncology disciplines in the fight against cancer. Recent data, reported in this supplement, suggest that interventional oncologic treatments for hepatocellular carcinoma can shrink tumors, relieve painful symptoms, improve quality of life, and potentially extend survival in patients who cannot be treated effectively with other approaches.